Physician profile
Ryan Gilbert
NPI 1497930234
$438.06
in general payments reported to CMS, 2019-2025
11 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.00 · 2020: $65.61 · 2021: $32.46 · 2022: $30.05 · 2023: $13.22 · 2024: $51.83 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $156.78 | 2021-2025 | Xpress Loprofile |
| Regeneron Healthcare Solutions, INC. | $53.15 | 2019-2024 | Dupixent |
| Inspire Medical Systems, INC. | $43.73 | 2025 | Inspire |
| Genzyme Corporation | $38.96 | 2019-2020 | |
| Intersect Ent, INC. | $32.56 | 2019-2021 | |
| Medtronic, INC. | $26.48 | 2023-2024 | Stealthstation S8 Platform |
| Lilly USA, LLC | $26.05 | 2025 | Zepbound, Mounjaro |
| Optinose US, INC. | $17.38 | 2020 | |
| Glaxosmithkline, LLC. | $16.55 | 2024 | Nucala |
| Merck Sharp & Dohme LLC | $15.19 | 2020 | |
| Cook Medical LLC | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.